Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14)
2.890
+0.340 (13.33%)
Oct 31, 2025, 5:10 PM SGT
SGX:T14 Market Cap
SGX:T14 has a market cap or net worth of 5.46 billion as of October 31, 2025. Its market cap has increased by 26.47% in one year.
Market Cap
5.46B
Enterprise Value
5.27B
Revenue
972.89M
Ranking
n/a
PE Ratio
8.42
Stock Price
2.89
Market Cap Chart
Since June 6, 2001, SGX:T14's market cap has increased from 1.52B to 5.46B, an increase of 260.31%. That is a compound annual growth rate of 5.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 5.46B | 41.05% |
| Dec 31, 2024 | 3.87B | -6.01% |
| Dec 29, 2023 | 4.12B | 16.09% |
| Dec 30, 2022 | 3.55B | -14.17% |
| Dec 31, 2021 | 4.13B | 82.26% |
| Dec 31, 2020 | 2.27B | 29.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Haw Par Corporation | 3.28B |
| Raffles Medical Group | 1.84B |
| Thomson Medical Group | 1.56B |
| Riverstone Holdings | 1.30B |
| Q & M Dental Group (Singapore) | 505.42M |
| Vicplas International | 50.09M |
| Cordlife Group | 38.45M |